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Abstract  28	
 29	
Human coronavirus 229E (HCoV-229E) is responsible for common colds. As other 30	
coronaviruses, HCoV-229E exploits cellular proteases to activate its fusion mediated by the 31	
spike protein. We analysed the proteolytic processing of the HCoV-229E spike protein by 32	
trypsin-like serine proteases leading to activation of the fusion process. Unlike other 33	
coronaviruses, HCoV-229E fusion activation appears to be a one step process. Indeed, 34	
cleavage of the S1/S2 interface does not seem to be a pre-requisite, and the fusion activation 35	
strongly relies on the S2’ region, with arginine residue 683 acting as the recognition site. 36	
 37	
Main text  38	
 39	
Coronavirinae are enveloped virus with a long positive sense RNA genome. As for other 40	
enveloped viruses, they need to fuse their viral envelope with a host cell membrane to deliver 41	
their genome to the target cell. Coronavirus spike proteins are major mediators of virus entry 42	
and fulfil a dual function by mediating receptor binding and fusion. Spike proteins consist of 43	
two distinct domains carrying these functions. The amino-terminal subunit, called S1 domain, 44	
is responsible for receptor binding, whereas the C-terminal part, called S2 domain, contains 45	
the fusion machinery. Proteolytic priming of coronavirus spike protein is a key feature of the 46	
fusion process, and coronaviruses exploit a wide variety of host proteases including 47	
cathepsins, furin and members of the transmembrane serine protease (TTSP) family [1] to 48	
achieve this requirement. It is likely that the proteolytic processing differs according to the 49	
protease used. Depending on the cellular localization of the protease used to activate the 50	
fusion, entry can occur either at the cell surface or after internalization of the virus by 51	
endocytosis. For SARS-CoV spike protein, two cleavage events mediated by trypsin have 52	
been identified. The SARS-CoV virion harbors an uncleaved spike protein at its surface. First, 53	
the spike protein is primed by cleavage of the S1 and S2 domain, then to fully activate fusion, 54	
a second cleavage occurs at a position called S2’ (R797) exposing the fusion peptide [2, 3]. 55	
Activation of the SARS-CoV spike protein fusion by elastase also involves recognition of a 56	
cleavage site in the S2’ region [4]. The importance of the S2’ cleavage has also been 57	
demonstrated for MERS-CoV and MHV [5, 6].  58	
HCoV-229E was identified in 1966 in students suffering from common cold [7], but children, 59	
elderly and immune-compromised persons can develop a more severe disease [8]. It has been 60	
shown that HCoV-229E requires endosomal cathepsin L activity to infect Hela cells [9]. 61	
However, Shirato et al. have recently shown that clinical isolates of HCoV-229E 62	
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preferentially uses the transmembrane protease serine 2 (TMPRSS2), a trypsin-like protease, 63	
rather than endosomal cathepsin for entry [10]. TMPRSS2 is known to be present at the 64	
surface of the human airway epithelia and is likely the main activator of HCoV-229E fusion 65	
in vivo. In addition, TMPRSS2-mediated entry at the cell surface protects the virus from the 66	
inhibitory effects of interferon-induced transmembrane proteins (IFITMs) known to inhibit 67	
entry of several enveloped virus [11]. However, the detailed proteolytic processing of HCoV-68	
229E spike protein to activate its fusion remains to elucidate. 69	
To investigate this proteolytic maturation, we first cloned the spike protein sequence from a 70	
patient infected by HCoV-229E hospitalized in Lille, France in 2014 (Spike 71	
France/Lille/2014, accession number MH048989).  The codon-optimized sequence of the 72	
France/Lille/2014 spike protein was inserted into the pCDNA3.1(+) vector and fused with a 73	
sequence encoding a C-terminal VSVG tag to facilitate the detection of the protein in 74	
immunoblot. Then, we analysed the proteolytic processing of the spike protein required for 75	
entry mediated by trypsin/trypsin like protease, focusing on the role of the S1/S2 junction and 76	
the S2’ region. The sequence of the French isolate spike protein shows 99% identity with the 77	
spike of the Niigata, 0349 and USA/932-72/1993 isolates and only 94% of identity with the 78	
VR-740 laboratory strain. HCoV-229E spike protein contains 3 arginine residues in the S2’ 79	
region (R679, R683 and R687) which are conserved in different strains of HCoV-229E, 80	
except for R679 that is absent in the VR-740 laboratory strain (Fig. 1(a)). First, to confirm the 81	
role of the HCoV-229E spike protein S2’ region in entry, we inserted a furin cleavage site 82	
(Fur687) in the spike protein (Fig.1(a)), at the N-terminal position of the potential fusion 83	
peptide. To analyse the effect of the mutation in the context of viral particles, we used a 84	
murine leukemia virus (MLV)-based pseudotyping system that produces particles inducing 85	
luciferase expression after transduction of permissive cells. Pseudoparticles fully mimic the 86	
functionality of the wild-type virus in terms of cell entry and were used because of their 87	
technical advantage. Huh-7 cells were inoculated with pseudoparticles harboring the wild type 88	
protein or the Fur687 mutant (Fig 1(b)). Neutralization of endosomal pH by ammonium 89	
chloride treatment inhibited transduction by HCoV-229E pseudoparticles showing that 90	
HCoV-229E infects Huh-7 cells via the endosomal route and uses low-pH active endosomal 91	
protease to mediate its fusion. As shown in Figure 1(b), pseudotyped virions with HCoV-92	
229E spike protein containing a furin cleavage site at the S2’ position were insensitive to 93	
endosomal pH neutralization, but were affected by furin convertase inhibitor. This result 94	
shows that the spike protein with the furin cleavage site does not rely on endosomal cathepsin 95	
for entry but relies on furin and this confirms the involvement of the S2’ region for fusion 96	
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activation of HCoV-229E, as observed for other coronaviruses [2, 5, 6, 12]. It is interesting to 97	
note that the spike proteins incorporated on the pseudotyped virions were not cleaved by furin 98	
in producing cells, indicating that the protein is not processed during exit of the producer cell 99	
but during entry into the target cell (Fig 1(d)). This suggests that during exit and secretion, the 100	
cleavage site is inaccessible to furin and that during entry, conformational change induced by 101	
receptor binding may expose the cleavage site. To investigate the role of the S1/S2 junction 102	
and the specific role of the 3 arginine residues located in the S2’ region (R679, R683 and 103	
R687) in the proteolytic activation of HCoV-229E spike protein by trypsin-like serine-104	
proteases, the arginine residues present at S1/S2 and at S2’ were mutated individually 105	
(R565N, R679N, R683N or R687N).  We chose to mutate the arginine residues into 106	
asparagine to minimize the effect of the mutations on the conformation/folding of the protein. 107	
As seen in Fig 1(c), these arginine residues were not implicated in entry when the virions use 108	
the endocytic pathway to invade the cells. The endosomal route of entry of the different 109	
mutants was confirmed by inhibition of their entry by ammonium chloride treatment (Fig 110	
1(c)). Indeed, when HCoV-229E is internalized, the virus is dependent on the endosomal 111	
cathepsin L to mediate its fusion. However, unlike other proteases, cathepsin L has a limited 112	
prime-site specificity in terms of recognition sites and the precise sites of proteolysis by 113	
cathepsin L remains unclear. 114	
In 2005, Simmons et al. showed that SARS-CoV fusion can be induced at the cell surface 115	
when virions are bound to the plasma membrane at 4°C and briefly treated by exogenous 116	
protease such as trypsin [13]. Particles pseudotyped with the different S1/S2 and S2’ arginine 117	
spike mutants were bound at the surface of Huh-7 cells treated with ammonium chloride to 118	
neutralize the endosomal pH and block the endosomal entry pathway. Then, fusion was 119	
induced by a brief trypsin treatment (Fig 2(a)). For the mutant R683N, trypsin treatment was 120	
not able to bypass the requirement for cathepsin L activity during the entry process, 121	
suggesting that proteolysis by trypsin occurs at R683 residue. Mutations of R679 or R687 had 122	
no effect on entry mediated by trypsin. Spike proteins of field strains of HCoV-229E contain 123	
an arginine at the position 679 whereas the laboratory strain VR-740 contains a threonine. 124	
Field strains were reported to use preferentially the TPPS pathway [10], this result suggest 125	
that acquisition of the arginine residue at the position 679 is not involved in this adaptation. It 126	
is surprising that mutation of R687 had no effect on entry mediated by trypsin. Indeed, R687 127	
is believed to be located at the N-terminus of the fusion peptide and the arginine residue 128	
located at the same position in the SARS-CoV spike protein is the major recognition site of 129	
trypsin. Unlike SARS-CoV, mutation of the arginine residue located at the S1/S2 junction 130	
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(R565N) has little effect on entry mediated at the cell surface by trypsin. In vivo, the major 131	
route of entry of respiratory coronavirus is believed to be mediated by the TTPS pathway. To 132	
confirm our results observed with trypsin, we expressed the human TMPRSS2 in Huh-7 cells 133	
with a lentiviral vector. Transduction of cells with a lentivirus expressing the human 134	
TMPRSS2 resulted in an increase in transduction by particles pseudotyped with the wild type 135	
S protein which was insensitive to ammonium chloride treatment (Fig 2(b)). As previously 136	
observed for the SARS-CoV [13, 14], HCoV-229E pseudotype entry mediated at the cell 137	
surface was more efficient than entry by the endocytic pathway. As seen with infection 138	
mediated by trypsin, mutation of the R683 abolished the capacity of the virus to use 139	
TMPRSS2 to infect the cells since its infectivity was sensitive to ammonium chloride 140	
treatment of the cells (Fig 2(c)). To further confirm that cleavage mediated by trypsin-like 141	
serine protease occurs at R683N, HEK293T cells transiently expressing the wild type or the 142	
different mutant proteins were treated by trypsin for 1h and then proteins at the cell surface 143	
were biotinylated at 4°C. After precipitation of biotinylated protein with streptavidin-144	
conjugated beads, cleavage products were analysed in western blotting with an antibody 145	
directed against a C-terminal tag of the protein. Spike proteins with a furin cleavage site 146	
introduced at the S1/S2 boundary (Fur565) or at the S2’ position (Fur687) were used as 147	
controls (Fig. 3). Cleavage by furin between the S1 and S2 domain gave rise to a band with a 148	
size below 135 kDa corresponding to the S2 domain. Cleavage at the S2’ position (Fur687) 149	
induces a cleavage product with a smaller size below 100 KDa. Contrary to other 150	
coronaviruses for which trypsin induces mainly a processing at the S1/S2 junction, cleavage 151	
of the wild-type HCoV-229E spike protein by trypsin resulted in the appearance of a cleavage 152	
product in western blot with a size similar to the one observed for the mutant Fur687, 153	
corresponding to the cleavage of the protein at the S2’ position. Mutation of R683 abolished 154	
the cleavage induced by trypsin confirming the proteolytic processing of the spike protein at 155	
this position by trypsin. The absence of any S2 fragment detection suggests that either the S2 156	
fragment is very short-lived, being rapidly processed at the S2’ position or that the S1/S2 157	
cleavage is not required for the S2’ cleavage. If the S2 fragment was short-lived, then 158	
mutation of R683 should lead to the accumulation of the intermediate cleavage product. 159	
However, we did not observe any accumulation of cleavage product of bigger size when R683 160	
was mutated, arguing again against the requirement of the S1/S2 cleavage to prime the 161	
cleavage at the S2’ position as shown for the SARS-CoV and MERS-CoV spike proteins [2, 162	
6]. 163	
	 6	
Taken together, our results show that activation of the fusion process by trypsin and trypsin-164	
like serine protease, particularly TMPRSS2 expressed in human airway epithelia, strongly 165	
rely on the R683 residue as a cleavage site. It has been shown that the position of the cleavage 166	
site in the S2’ region of the SARS-CoV spike protein can be shifted from the position relative 167	
to the fusion peptide but with some effects on fusion activation and infection. Indeed, for the 168	
SARS-CoV spike protein, cleavage at the N-terminus of the fusion peptide results in 169	
improved fusion and infection capacities [4]. For HCoV-229E spike protein, the cleavage site 170	
by trypsin is not located at the N-terminus of the fusion peptide but is present 3 residues 171	
upstream. For the SARS-CoV spike protein, even if the location of the cleavage site presents 172	
some flexibility, certain position in the vicinity of the fusion peptide were also not accessible 173	
to protease. Indeed, no cleavage product was observed when R683 was mutated (Fig 3), 174	
suggesting that both arginine residues 679 and 687 were not accessible to the protease, 175	
otherwise, if these residues could be cleaved but without being functional to activate the 176	
fusion, the same band would have been observed with the R683N mutant. 177	
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FIGURE LEGEND 231	
Figure 1 232	
(A) Alignment of the S1/S2 and S2’ region of different coronavirus spike protein (HCoV-233	
229E isolated in France, 2014, HCoV-229E Niigata/01/08, HCoV-229E 0349, HCoV-229E 234	
USA/932-72/1993, HCoV-229E laboratory strain VR-740, MERS-CoV and SARS-CoV). 235	
R565 at the S1/S2 boundary is in red and R679, R683 and R687 are presented in green. For 236	
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SARS-CoV and MERS-CoV the arginine at the S2’ position is also presented in green. The 237	
amino sequence between the S1/S2 boundary and the S2’ region is not totally presented and 238	
the omitted sequence is depicted by a dotted line. (B) MLV-based particles pseudotyped with 239	
the wild type spike protein (WT) or with a spike protein in which a furin cleavage site was 240	
introduced in the S2’ region (Fur687) were produced and used to inoculate Huh-7 cells in 241	
presence or absence of 25 mM NH4Cl or 5 μM of furin inhibitor. Results are presented as the 242	
percentage of transduction in absence of drug (DMSO) and are expressed as the mean of three 243	
independent experiments. Error bars represent the standard error of the means (SEM). Data 244	
were analysed by using an ANOVA test (*** P<0.001).  (C) Endosomal entry of particles 245	
pseudotyped with the mutated spike proteins. Pseudoparticles were produced and used to 246	
inoculate Huh-7 cells at 37°C in presence or absence of 25 mM NH4Cl. 48h later, the cells 247	
were lysed and luciferase activity was measured. Results are presented as relative light units 248	
(RLU) and are expressed as the mean of five independent experiments. Error bars represent 249	
the standard error of the means (SEM). Data were analysed by using an ANOVA test (*** 250	
P<0.001). (D) Analysis of pseudoparticles formation. Pseudoparticles were produced with the 251	
different mutated spike proteins and concentrated on sucrose cushion, then pseudoparticles 252	
were lysed and the production was analysed by western blotting with anti-VSVG antibody to 253	
detect the spike protein and anti-gag antibody.  254	
 255	
Figure 2 256	
(A). Trypsin-mediated entry at the cell surface. Particles pseudotyped with the different 257	
mutated spike proteins were bound at the cell surface at 4°C in presence of 25 mM NH4Cl 258	
and were treated with a 5 min incubation with 2 μg/ml of trypsin to induce fusion. 48h later, 259	
the cells were lysed and luciferase activity was measured. Results are presented as the 260	
percentage of transduction observed with particles pseudotyped with the wild type protein and 261	
are expressed as the mean of three independent experiments. Error bars represent the standard 262	
error of the means (SEM). Data were analysed by using an ANOVA test (** P<0.01) (B) 263	
Huh-7 cells were transduced or not with a lentivirus expressing the human TMPRSS2. Then 264	
cells were infected with particles pseudotyped with the wild type spike protein in presence or 265	
absence of 25 mM NH4Cl. Results are presented as relative light units (RLU) and are 266	
expressed as the mean of three independent experiments. Data were analysed by using an 267	
ANOVA test (*** P<0.001). (C) Huh-7 cells transduced or not with a lentivirus expressing 268	
TMPRSS2 were inoculated with particles pseudotyped with the different mutated spike 269	
proteins. Results are presented as the percentage of infection observed with particles 270	
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pseudotyped with the wild type protein and are expressed as the mean of three independent 271	
experiments. Error bars represent the standard error of the means (SEM). Data were analysed 272	
by using an ANOVA test (*** P<0.001). 273	
 274	
Figure 3 275	
Spike protein cleavage with trypsin. HEK293T cells were transfected with plasmid encoding 276	
the different mutated spike protein. 48h later, cells were treated for 1h with 2μg/ml of trypsin 277	
at 37°C. Then cell surface protein were biotinylated at 4°C and the cells were lysed. 278	
Biotinylated protein were precipitated with streptavidin-conjugated beads and analysed by 279	
western blotting with the C-terminal part of the protein detected with an anti-VSVG antibody.  280	
 281	
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